Glycemic, Lipid, and Blood Pressure Control Among Individuals with Type 2 Diabetes Mellitus in Saudi Arabia.

Osenenko, K M; Szabo, S M; Donato, B M K; Korol, E E; Qatami, L; Al Jaser, S; Al Saggabi, A; El Seid, M E; Maclean, R; Levy, A R

Osenenko, K M; Szabo, S M; Donato, B M K; Korol, E E; Qatami, L; Al Jaser, S; Al Saggabi, A; El Seid, M E; Maclean, R; Levy, A R.

Afiliación

Osenenko KM; ICON Epidemiology, Vancouver, BC, Canada.
Szabo SM; ICON Epidemiology, Vancouver, BC, Canada.
Donato BM; Bristol-Myers Squibb Company, Wallingford, CT, USA.
Korol EE; ICON Epidemiology, Vancouver, BC, Canada.
Qatami L; Bristol-Myers Squibb Company, Dubai, United Arab Emirates.
Al Jaser S; King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
Al Saggabi A; King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
El Seid ME; King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
Maclean R; Bristol-Myers Squibb Company, Plainsboro, NJ, USA.
Levy AR; ICON Epidemiology, Vancouver, BC, Canada.

Value Health ; 17(7): A333-4, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27200581

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google